Updated 28 July 2008
The location of the solitary plasmacytoma is crucial to predicting its natural history. The majority of patients with extra-osseous (non-bone-involving) plasmacytoma have localized disease which is potentially curable with irradiation. The majority of patients with solitary plasmacytoma of bone will eventually manifest overt multiple myeloma.
3.1 Diagnosis
All these criteria must be present:
A serum and/or urine monoclonal paraprotein may be present. Usually the uninvolved immunoglobulin levels are normal.
3.2 Staging
No standard system is available. Patients should undergo all the usual tests for multiple myeloma. CT scan of the plasmacytoma should be obtained prior to radiation therapy.
3.3 Treatment
Standard treatment for solitary plasmacytoma is irradiation to the entire lesion with appropriate margins.
3.4 Follow-up
Solitary extra-osseous plasmacytoma
|
Tests |
Interval |
|
CBC serum creatinine, calcium serum protein electrophoresis |
Every 3 months x 1 year then 6 months x 2 years then annual |
Solitary plasmacytoma of bone
|
Tests |
Interval |
|
CBC serum creatinine, calcium serum protein electrophoresis |
Every 3 months x 1 year then 6 months |
Patients with either type of plasmacytoma should have a 24 hour urine protein electrophoresis and skeletal survey annually. Those patients with extra-osseous plasmacytomas do not require these extra tests after they have been well for 5 years.